EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cutaneous manifestations of cystic fibrosis

Aaron D Smith, Gabrielle Schwartzman, Catherine E Lyons, Hal Flowers, Dana Albon, Kenneth Greer, Kevin Lonabaugh, Barrett J Zlotoff

Journal of the American Academy of Dermatology · 2024

DOI: 10.1016/j.jaad.2024.04.052 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Academy of Dermatology, 2024. Verfasst von Aaron D Smith und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Virginia School of Medicine, Charlottesville, Virginia. Electronic address: KDF2EB@virginia.edu. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 109 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis (CF) is caused by a mutation in the Cystic fibrosis transmembrane conductance regulator (CFTR) gene, and features recurrent sinus and pulmonary infections, steatorrhea, and malnutrition. CF is associated with diverse cutaneous manifestations, including transient reactive papulotranslucent acrokeratoderma of the palms, nutrient deficiency dermatoses, and vasculitis. Rarely these are presenting symptoms of CF, prior to pulmonary or gastrointestinal sequelae. Cutaneous drug eruptions are also highly common in patients with CF (PwCF) given frequent antibiotic exposure. Finally, CFTR modulating therapy, which has revolutionized CF management, is associated with cutaneous side effects ranging from acute urticaria to toxic epidermal necrolysis. Recognition of dermatologic clinical manifestations of CF is important to appropriately care for PwCF. Dermatologists may play a significant role in the diagnosis and management of CF and associated skin complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorHumansSkin DiseasesDrug EruptionsAnti-Bacterial Agents

Stichwörter der Autor:innen

CFTRCystic fibrosisadverse eventsnutrient deficiency dermatitistransient reactive papulotranslucent acrokeratoderma of the palmvasculitis

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorAnti-Bacterial Agents

Autor:innen und Institutionen

  • University of Virginia School of Medicine, Charlottesville, Virginia. Electronic address: KDF2EB@virginia.edu.
  • Department of Dermatology, University of Virginia, Charlottesville, Virginia.
  • University of Virginia School of Medicine, Charlottesville, Virginia.
  • Department of Pulmonology and Critical Care Medicine, University of Virginia, Charlottesville, Virginia.

Zitieren

APA

Smith, A. D., Schwartzman, G., Lyons, C. E., Flowers, H., Albon, D., Greer, K., Lonabaugh, K., & Zlotoff, B. J. (2024). Cutaneous manifestations of cystic fibrosis. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2024.04.052

Vancouver

Smith AD, Schwartzman G, Lyons CE, Flowers H, Albon D, Greer K, et al. Cutaneous manifestations of cystic fibrosis. Journal of the American Academy of Dermatology. 2024. doi:10.1016/j.jaad.2024.04.052

BibTeX
@article{Smith2024,
  author = {Smith, Aaron D and Schwartzman, Gabrielle and Lyons, Catherine E and Flowers, Hal and Albon, Dana and Greer, Kenneth and Lonabaugh, Kevin and Zlotoff, Barrett J},
  title = {Cutaneous manifestations of cystic fibrosis},
  journal = {Journal of the American Academy of Dermatology},
  year = {2024},
  doi = {10.1016/j.jaad.2024.04.052}
}
Kostenlos starten →